Editorial
|
| Qing tumor glutaminase for therapy |
|
https://doi.org/10.18632/oncotarget.6301
|
| 38440-38441 |
|
| Mitochondrial mass and DNA repair in breast cancer stem cells |
|
https://doi.org/10.18632/oncotarget.6305
|
| 38442-38443 |
|
| Inflammasome effects in GvHD |
|
https://doi.org/10.18632/oncotarget.6307
|
| 38444-38445 |
Research Perspectives
|
| Glucocorticoidinduced leucine zipper GILZ in immuno suppression: master regulator or bystander |
|
https://doi.org/10.18632/oncotarget.6197
|
| 38446-38457 |
Priority Research Papers
|
| Intermittent highdose treatment with erlotinib enhances therapeutic efficacy in EGFRmutant lung cancer |
|
https://doi.org/10.18632/oncotarget.6276
|
| 38458-38468 |
|
| LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferation |
|
https://doi.org/10.18632/oncotarget.6288
|
| 38469-38486 |
|
| An inducible transgenic mouse breast cancer model for the analysis of tumor antigen specific CD8+ Tcell responses |
|
https://doi.org/10.18632/oncotarget.5750
|
| 38487-38503 |
Research Papers: Immunology
|
| Recombinant rabies virus expressing dog GMCSF is an efficacious oral rabies vaccine for dogs |
|
https://doi.org/10.18632/oncotarget.5904
|
| 38504-38516 |
|
| PPE26 induces TLR2dependent activation of macrophages and drives Th1type Tcell immunity by triggering the crosstalk of multiple pathways involved in the host response |
|
https://doi.org/10.18632/oncotarget.5956
|
| 38517-38537 |
|
| The cAMP response element modulator CREM regulates TH2 mediated inflammation |
|
https://doi.org/10.18632/oncotarget.6041
|
| 38538-38551 |
|
| Chromosomal instability triggers cell death via local signalling through the innate immune receptor Toll |
|
https://doi.org/10.18632/oncotarget.6035
|
| 38552-38565 |
|
| Decreased severity of collagen antibody and lipopolysaccharideinduced arthritis in human IL32β overexpressed transgenic mice |
|
https://doi.org/10.18632/oncotarget.6160
|
| 38566-38577 |
|
| Hepatic TLR4 signaling is activated by LPS from digestive tract during SARA and epigenetic mechanisms contribute to enforced TLR4 expression |
|
https://doi.org/10.18632/oncotarget.6161
|
| 38578-38590 |
Reviews
|
| MYCdriven aggressive Bcell lymphomas: biology entity differential diagnosis and clinical management |
|
https://doi.org/10.18632/oncotarget.5774
|
| 38591-38616 |
|
| Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility |
|
https://doi.org/10.18632/oncotarget.5775
|
| 38617-38627 |
|
| miRNA interventions serve as ‘magic bullets’ in the reversal of glioblastoma hallmarks |
|
https://doi.org/10.18632/oncotarget.5926
|
| 38628-38642 |
|
| Detection of cancer through exhaled breath: a systematic review |
|
https://doi.org/10.18632/oncotarget.5938
|
| 38643-38657 |
Research Papers
|
| Pattern of distant metastases in colorectal cancer: a SEER based study |
|
https://doi.org/10.18632/oncotarget.6130
|
| 38658-38666 |
|
| Hes1 promotes cell proliferation and migration by activating Bmi1 and PTEN/Akt/GSK3β pathway in human colon cancer |
|
https://doi.org/10.18632/oncotarget.5484
|
| 38667-38680 |
|
| Wholetranscriptome analysis of flowsorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival |
|
https://doi.org/10.18632/oncotarget.4526
|
| 38681-38694 |
|
| MicroRNA expression profiling identifies miR315p/3p as associated with time to progression in wildtype RAS metastatic colorectal cancer treated with cetuximab |
|
https://doi.org/10.18632/oncotarget.5735
|
| 38695-38704 |
|
| microRNA214 promotes epithelialmesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressoroffused protein Sufu |
|
https://doi.org/10.18632/oncotarget.5478
|
| 38705-38718 |
|
| A link between lipid metabolism and epithelialmesenchymal transition provides a target for colon cancer therapy |
|
https://doi.org/10.18632/oncotarget.5340
|
| 38719-38736 |
|
| Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal |
|
https://doi.org/10.18632/oncotarget.5395
|
| 38737-38748 |
|
| Cytokeratin19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis |
|
https://doi.org/10.18632/oncotarget.5501
|
| 38749-38763 |
|
| A microfluidic approach towards hybridoma generation for cancer immunotherapy |
|
https://doi.org/10.18632/oncotarget.5550
|
| 38764-38776 |
|
| Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors |
|
https://doi.org/10.18632/oncotarget.6091
|
| 38777-38788 |
|
| In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in nonsmallcell lung cancer |
|
https://doi.org/10.18632/oncotarget.5887
|
| 38789-38803 |
|
| Association of the EGFTM7 receptor CD97 expression with FLT3ITD in acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.5661
|
| 38804-38815 |
|
| Deletion of cyclooxygenase2 inhibits Kras–induced lung carcinogenesis |
|
https://doi.org/10.18632/oncotarget.5558
|
| 38816-38826 |
|
| Biomarkerdriven stratification of diseaserisk in nonmetastatic medulloblastoma: Results from the multicenter HITSIOPPNET4 clinical trial |
|
https://doi.org/10.18632/oncotarget.5149
|
| 38827-38839 |
|
| Synergistic antitumor efficacy against the EGFRvIII+HER2+ breast cancers by combining trastuzumab with antiEGFRvIII antibody CH12 |
|
https://doi.org/10.18632/oncotarget.6111
|
| 38840-38853 |
|
| MDP a database linking drug response data to genomic information identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cells |
|
https://doi.org/10.18632/oncotarget.5749
|
| 38854-38865 |
|
| Interleukin1 beta transactivates epidermal growth factor receptor via the CXCL1CXCR2 axis in oral cancer |
|
https://doi.org/10.18632/oncotarget.5640
|
| 38866-38880 |
|
| Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes |
|
https://doi.org/10.18632/oncotarget.6195
|
| 38881-38900 |
|
| CD40 controls CXCR5induced recruitment of myeloidderived suppressor cells to gastric cancer |
|
https://doi.org/10.18632/oncotarget.5644
|
| 38901-38911 |
|
| Tunicamycin enhances the antitumor activity of trastuzumab on breast cancer in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.5334
|
| 38912-38925 |
|
| Potential role of aquaporin 3 in gastric intestinal metaplasia |
|
https://doi.org/10.18632/oncotarget.5370
|
| 38926-38933 |
|
| Inhibition of cMYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells |
|
https://doi.org/10.18632/oncotarget.5380
|
| 38934-38951 |
|
| The BH3mimetic gossypol and noncytotoxic doses of valproic acid induce apoptosis by suppressing cyclinA2/Akt/FOXO3a signaling |
|
https://doi.org/10.18632/oncotarget.5731
|
| 38952-38966 |
|
| Regulation of Aldoketoreductase family 1 B10 by 1433ε and their prognostic impact of hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.5734
|
| 38967-38982 |
|
| Role of miR182 in response to oxidative stress in the cell fate of human fallopian tube epithelial cells |
|
https://doi.org/10.18632/oncotarget.5493
|
| 38983-38998 |
|
| Identification of the βcatenin/JNK/prothymosinalpha axis as a novel target of sorafenib in hepatocellular carcinoma cells |
|
https://doi.org/10.18632/oncotarget.5738
|
| 38999-39017 |
|
| Neutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin oxaliplatin and 5fluorouracil regimen |
|
https://doi.org/10.18632/oncotarget.5730
|
| 39018-39027 |
|
| NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patientderived tumor cell line |
|
https://doi.org/10.18632/oncotarget.5494
|
| 39028-39035 |
|
| Necrosis avid near infrared fluorescent cyanines for imaging cell death and their use to monitor therapeutic efficacy in mouse tumor models |
|
https://doi.org/10.18632/oncotarget.5498
|
| 39036-39049 |
|
| RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration |
|
https://doi.org/10.18632/oncotarget.5176
|
| 39050-39061 |
|
| IGK with conserved IGΚV/IGΚJ repertoire is expressed in acute myeloid leukemia and promotes leukemic cell migration |
|
https://doi.org/10.18632/oncotarget.5393
|
| 39062-39072 |
|
| Simple and rapid determination of homozygous transgenic mice via in vivo fluorescence imaging |
|
https://doi.org/10.18632/oncotarget.5535
|
| 39073-39087 |
|
| Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and metaanalysis |
|
https://doi.org/10.18632/oncotarget.5142
|
| 39088-39097 |
|
| An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype |
|
https://doi.org/10.18632/oncotarget.5390
|
| 39098-39110 |
|
| Oncogenic features of the bone morphogenic protein 7 BMP7 in pheochromocytoma |
|
https://doi.org/10.18632/oncotarget.4912
|
| 39111-39126 |
|
| Prognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomas |
|
https://doi.org/10.18632/oncotarget.3926
|
| 39127-39139 |
|
| Gemcitabine triggers angiogenesispromoting molecular signals in pancreatic cancer cells: Therapeutic implications |
|
https://doi.org/10.18632/oncotarget.3784
|
| 39140-39150 |
|
| SubpathwayGMir: identifying miRNAmediated metabolic subpathways by integrating conditionspecific genes microRNAs and pathway topologies |
|
https://doi.org/10.18632/oncotarget.5341
|
| 39151-39164 |
|
| miRNAs in multiple myeloma – a survival relevant complex regulator of gene expression |
|
https://doi.org/10.18632/oncotarget.5381
|
| 39165-39183 |
|
| Effects of interferons and doublestranded RNA on human prostate cancer cell apoptosis |
|
https://doi.org/10.18632/oncotarget.5508
|
| 39184-39195 |
|
| Bladder cancer cells reeducate TAMs through lactate shuttling in the microfluidic cancer microenvironment |
|
https://doi.org/10.18632/oncotarget.5538
|
| 39196-39210 |
|
| REC8 is a novel tumor suppressor gene epigenetically robustly targeted by the PI3K pathway in thyroid cancer |
|
https://doi.org/10.18632/oncotarget.5391
|
| 39211-39224 |
|
| miR454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.4407
|
| 39225-39234 |
|
| NOX5L can stimulate proliferation and apoptosis depending on its levels and cellular context determining cancer cell susceptibility to cisplatin |
|
https://doi.org/10.18632/oncotarget.5743
|
| 39235-39246 |
|
| Depletion of the thiol oxidoreductase ERp57 in tumor cells inhibits proliferation and increases sensitivity to ionizing radiation and chemotherapeutics |
|
https://doi.org/10.18632/oncotarget.5746
|
| 39247-39261 |
|
| NFκB contributes to MMP1 expression in breast cancer spheroids causing paracrine PAR1 activation and disintegrations in the lymph endothelial barrier in vitro |
|
https://doi.org/10.18632/oncotarget.5741
|
| 39262-39275 |
|
| A803467 a tetrodotoxinresistant sodium channel blocker modulates ABCG2mediated MDR in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.5747
|
| 39276-39291 |
|
| Evaluation of pentacyclic triterpenes found in Perilla frutescens for inhibition of skin tumor promotion by 12Otetradecanoylphorbol13acetate |
|
https://doi.org/10.18632/oncotarget.5751
|
| 39292-39306 |
|
| Stromal cells promote antiestrogen resistance of breast cancer cells through an insulinlike growth factor binding protein 5 IGFBP5/Bcell leukemia/lymphoma 3 Bcl3 axis |
|
https://doi.org/10.18632/oncotarget.5624
|
| 39307-39328 |
|
| Suppression of mTOR pathway and induction of autophagydependent cell death by cabergoline |
|
https://doi.org/10.18632/oncotarget.5744
|
| 39329-39341 |
|
| Celecoxib increases lung cancer cell lysis by lymphokineactivated killer cells via upregulation of ICAM1 |
|
https://doi.org/10.18632/oncotarget.5745
|
| 39342-39356 |
Clinical Research Papers
|
| The diagnostic and prognostic value of MRP8/MRP14 in intrahepatic cholangiocarcinoma |
|
https://doi.org/10.18632/oncotarget.5329
|
| 39357-39364 |
|
| Efficacy and safety of capecitabinebased firstline chemotherapy in advanced or metastatic breast cancer: a metaanalysis of randomised controlled trials |
|
https://doi.org/10.18632/oncotarget.5460
|
| 39365-39372 |
|
| Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensitymodulated radiotherapy and chemotherapy |
|
https://doi.org/10.18632/oncotarget.5781
|
| 39373-39383 |
Errata
|
| Erratum: Changes in expression levels of ERCC1 DPYD and VEGFA mRNA after firstline chemotherapy of metastatic colorectal cancer: results of a multicenter study |
|
https://doi.org/10.18632/oncotarget.6335
|
| 39384-39384 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
